[go: up one dir, main page]

KR970005914B1 - Process for gmp by recombinant microorganism - Google Patents

Process for gmp by recombinant microorganism Download PDF

Info

Publication number
KR970005914B1
KR970005914B1 KR1019910013227A KR910013227A KR970005914B1 KR 970005914 B1 KR970005914 B1 KR 970005914B1 KR 1019910013227 A KR1019910013227 A KR 1019910013227A KR 910013227 A KR910013227 A KR 910013227A KR 970005914 B1 KR970005914 B1 KR 970005914B1
Authority
KR
South Korea
Prior art keywords
gmp
pgh
aminase
gene
xmp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019910013227A
Other languages
Korean (ko)
Other versions
KR930002508A (en
Inventor
한종권
이현환
정성오
현형환
Original Assignee
제일제당 주식회사
김정순
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제일제당 주식회사, 김정순 filed Critical 제일제당 주식회사
Priority to KR1019910013227A priority Critical patent/KR970005914B1/en
Publication of KR930002508A publication Critical patent/KR930002508A/en
Application granted granted Critical
Publication of KR970005914B1 publication Critical patent/KR970005914B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

내용 없음.No content.

Description

유전자 재조합 미생물에 의한 5'-구아닐산의 제조방법Method for preparing 5'-guanylic acid by recombinant microorganism

제1도는 pGH 16의 제한 효소 Sal I, Xba I, Pst I의 절단 지도 및 그의 형성 단계를 나타낸 것이다.Figure 1 shows the cleavage map of the restriction enzymes Sal I, Xba I, Pst I of pGH 16 and its formation steps.

본 발명은 재조합 유전자조작법에 의해 5'-크산틸산 아미나제(XMP aminase)가 강화된 미생물을 이용하여 5'-크산틸산(이후 XMP라 칭한다)을 5'-구아닐산(이후 GMP라 칭한다)으로 전환시키는 GMP의 제조방법에 관한 것이다. 퓨린계 핵산의 일종인 GMP는 5'-이노신산(이후 IMP라 칭한다), XMP와 더불어 정미성이 뛰어난 핵산계 조미료로서 널리 알려져 있는 물질이다. 종래 GMP의 제조방법으로는 1) 효모의 리보핵산(ribonucleic acid)을 리보뉴클레아제(ribonuclease), 포스포디에스터라제(phosphodiesterase) 등의 효소에 의해 가수분해 시키는 방법, 2) 미생물에 의하여 제조된 구아노신을 인산화시키는 방법이 있으나, 이들방법은 원료공급의 문제라든가 수율 및 생성량이 적은 점 등의 여러 가지 단점이 많으며, 3) 미생물 변이주에 의한 직접발효법도 있으나 생체내 GMP의 합성경로가 매우 복잡한 조절기작을 보이고 있어 목적물 이외의 부산물이 생성되며 최종산물인 GMP의 세포막 투과성이 매우 낮아 배지중에 그 축적량이 작기 때문에 계면활성제나 방부제를 첨가하는 방법 등을 사용하여야 하므로 공업적인 면에서 실용성이 희박한 제조방법으로 알려져 있다. 4) 크산틴이나 크산토신으로부터의 발효 전환방법도 발표되었으나 전구물질의 공급이 어려운 결점이 있다. 5) 두 종의 미생물을 혼합배양하여 GMP를 제조하는 방법도 있으나 두 종의 미생물을 동시에 배양하여야 하므로 배양조절(control)이 용이하지 않고 특히 GMP 이외의 부산물이 생성되므로 바람직한 제조방법이 될 수 없다. 근래에는 6) 미생물 변이주를 이용하여 배양액에 XMP를 축적하고 여기에 5'-크산틸산 아미나제가 강화된 변이주를 배양하여 XMP를 GMP로 전환시키는 2단계의 생산방법이 널리 이용되고 있다.(일본 특허공고 39069/71, 일본 특허공개 78697/84, 대한민국 특허공고 78-344)The present invention converts 5'-xanthyl acid (hereinafter referred to as XMP) into 5'-guanylic acid (hereinafter referred to as GMP) using a microorganism enriched in 5'-xanthyl acid aminase by recombinant genetic engineering. It relates to a method of manufacturing GMP. GMP, a kind of purine-based nucleic acid, is widely known as 5'-inosinic acid (hereinafter referred to as IMP) and XMP as a nucleic acid-based seasoning having excellent taste. Conventional methods of manufacturing GMP include 1) hydrolyzing ribonucleic acid in yeast by enzymes such as ribonuclease, phosphodiesterase, and 2) producing by microorganisms. There are many methods of phosphorylating guanosine, but these methods have many disadvantages such as problems of raw material supply, low yield, and low yield. 3) Direct fermentation by microbial mutants, but the synthetic route of in vivo GMP is very complicated. Since the byproducts other than the target product are produced, and the final product GMP cell membrane permeability is very low, the amount of accumulation in the medium is small, so the method of adding surfactants or preservatives should be used. Known as 4) A method of converting fermentation from xanthine or xanthosine has been announced, but the supply of precursors is difficult. 5) There is also a method of producing GMP by mixing and culturing two kinds of microorganisms, but since two kinds of microorganisms must be cultured at the same time, it is not easy to control the culture, and in particular, by-products other than GMP are generated, and thus it cannot be a preferable manufacturing method. . 6) Recently, a two-step production method of accumulating XMP in a culture medium using microbial mutant strains and incubating mutant strains fortified with 5'-xanthyl acid aminase converts XMP to GMP is widely used. Publication 39069/71, Japanese Patent Publication 78697/84, Korean Patent Publication 78-344)

5'-크산틸산 아미나제는 하기와 같은 반응기전을 가지고 있다.5'-xanthyl acid aminase has the following reactor field.

5'-크산틸산 아미나제가 강화된 변이주를 얻기 위해서는 미생물에 돌연변이원을 처리하여 5'-크산틸산 아미나제를 특이적으로 저해하는 물질인 데코이닌(decoyinine)에 대한 내성을 부여함으로써 XMP의 GMP로의 전환활성을 강화시킬 수 있다는 것이 발표된 바 있다. 대장균의 경우에는 GMP의 합성에 관여하는 효소인 5'-이노신산 디히드로게나제(IMP dehydrogenase, guaB)와 5'-크산틸산 아미나제(XMP aminase, guaA)가 오페론(operon)을 이루고 있으며, 그 순서는 조절유전자(operator), guaB, guaA의 순으로 구성되어 있다는 것이 보고되어 있으며,(J. Bacteriol. 115, 992-1002(1973)), 대장균의 경우에는 5'-크산틸산 아미나제를 코딩하는 guaA 유전자가 클로닝된 형질전환주를 이용하여 XMP로부터의 GMP로의 전환생산에 사용된 예가 보고되어 있다(일본 특허공개 224498/85, Agric. biol. Chem. 50, 1879-1884(1986)). 그러나 아미노산 및 핵산의 생산에 많이 사용되는 코리네박테리움 및 브레비박테리움 등의 코리네형 세균으로부터의 5'-크산틸산 아미나제의 유전자의 클로닝 및 그의 이용에 관한 보고가 전혀 없는 실정이다. 본 발명은 5'-크산틸산 아미나제가 강화된 당사 발명 균주인 브레비박테리움 암모니아게네스( Brebibacterium ammoniagenes) BA 17-2 균주로부터 5'-크산틸산 아미나제를 코딩(coding)하는 유전자를 당사 개발의 에쉐리시아/코리네박테리움 셔틀벡터 pECCG 117을 이용하여 클로닝하고 이 5'-크산틸산 아미나제의 유전 정보를 갖는 재조합 플라스미드를 적당한 균주에 형질전환하여 5'-크산틸산 아미나제의 역가를 향상시키고 이 5'-크산틸산 아미나제 역가가 향상된 형질전화주를 이용하여 보다 효율적으로 XMP를 GMP로 전환시키는 유전자 재조합 미생물에 의한 GMP의 제조방법에 관한 것이다. 본 발명자들은 코리네형 글루타메이트 생산균의 숙주-벡터계의 개발을 위해 코리네박테리움 글루타미쿰 ATCC 13058 균주로부터 크립틱 플라스미드(cryptic plasmid)인 PCG 1을 분리한 뒤 에쉐리시아 콜리 속 균주의 클로닝 벡터(cloning vector)인 pACYC 177과 결합시켜 코리네박테리움과 에쉐리시아 속의 균주들에서 모두 형질전환 및 발현이 가능한 셔틀벡터인 pECCG 1을 제작하였으며, 이 pECCG 1으로부터 앰피실린 내성 유전자 부분을 제거하고 플라스미드 pBluescript Ⅱ KS+의 다발성 절단부위(multi-cloning site)를 도입하여 코리네박테리움 속의 균주에서 안정하게 발현되는 셔틀벡터 pECCG 117을 제작하여 특허출원 한 바 있으며(대한민국 특허출원 89-5569 및 90-9199), 이 셔틀벡터 pECCG 117은 코리네박테리움 속 균주 뿐만 아니라 코리네형 글루타메이트 생산균의 일종인 브레비박테리움 속의 균주에서도 형질발현 및 안정성이 유지되는 것을 확인하고 본 발명에 이용하였으며, 본 발명에 사용된 균주 및 플라스미드는 표 1과 같다.To obtain a mutant strain enriched with 5'-xanthyl acid aminase, XMP can be transferred to GMP by giving microorganisms resistance to decoinine, a substance that specifically inhibits 5'-xanthyl acid aminase. It has been announced that it can enhance the conversion activity. In E. coli, 5'-inosinic acid dehydrogenase (IMP dehydrogenase, guaB) and 5'-xanthyl acid aminase (XMP aminase, guaA), enzymes involved in the synthesis of GMP, form an operon. It is reported that the sequence consists of the sequence of operator, guaB, and guaA (J. Bacteriol. 115, 992-1002 (1973)), and in the case of E. coli coding for 5'-xanthyl acid aminase. An example has been reported for the production of conversion from XMP to GMP using a transformant cloned with a guaA gene (Japanese Patent Publication No. 224498/85, Agric. Biol. Chem. 50, 1879-1884 (1986)). However, there have been no reports on the cloning and use of 5'-xanthyl acid aminase genes from coryneform bacteria such as Corynebacterium and Brevibacterium, which are widely used for the production of amino acids and nucleic acids. The present invention developed a gene encoding 5'-xanthyl acid aminase from Brebibacterium ammoniagenes BA 17-2 strain, which is a strain of the invention, which is enhanced with 5'-xanthyl acid aminase. The recombinant plasmid containing the genetic information of this 5'-xanthyl acid aminase was transformed into a suitable strain by cloning using the E. colibacterium shuttle vector pECCG 117 of the present invention to determine the titer of 5'-xanthyl acid aminase. The present invention relates to a method for producing GMP by a recombinant microorganism which improves and converts XMP into GMP more efficiently using a transfection line having an improved 5'-xanthyl acid aminase titer. The present inventors isolated the cryptic plasmid PCG 1 from the Corynebacterium glutamicum ATCC 13058 strain for the development of a host-vector system of coryneform glutamate producing bacteria and then cloned the strain of Escherichia coli. By combining with the cloning vector pACYC 177, a pECCG 1, a shuttle vector capable of transforming and expressing both strains of Corynebacterium and E. coli, was constructed, and the ampicillin resistance gene portion was removed from the pECCG 1. A multi-cloning site of the plasmid pBluescript II KS + was introduced to produce a shuttle vector, pECCG 117, which is stably expressed in strains of the genus Corynebacterium, and applied for a patent (Korean Patent Application 89-5569 and 90-9199), this shuttle vector pECCG 117 is not only a strain of the genus Corynebacterium, but also Brevibac, a kind of coryneform glutamate producing bacteria. It was confirmed that the expression and stability is maintained even in the strain of the terriium was used in the present invention, the strains and plasmids used in the present invention are shown in Table 1.

재조합 플라스미드를 운반하는 형질전환체에 의한 XMP로부터의 GMP로의 전환을 위한 5'-크산틸산 아미나제를 내는 효소균의 배양은 공지의 방법에 의해 수행될 수 있다. 즉, 형질전환체를 온도 pH 등을 조절하면서 호기성 조건하에 탄소원, 질소원, 무기화합물, 아미노산, 비타민 및 기타 영양요구 물질 등을 함유한 통상의 배양배지에 배양하여 생성된 균체를 전환반응의 효소원으로 사용한다. 탄소원으로는, 글루코오즈, 프럭토오즈, 슈트로오즈, 말토오즈, 만노오즈 및 당밀 같은 각종 탄수화물, 피루브산, 푸마르산, 락트산 및 아세트산과 같은 각종 유기산이 사용될 수 있고, 질소원으로는 암모니아, 염화암모늄, 황산암모늄, 탄산암모늄 및 초산암모늄과 같은 각종 무기 및 유기암모늄 염, 우레아 및 기타 질소 함유 물질 및 펩톤, NZ-아민, 육류추출물, 효모추출물, 옥수수침지액, 카세인 가수분해물, 어류 또는 그의 분해생성물, 탈지대두케이크, 또는 그의 분해 생성물 등이 사용될 수 있다. 무기 화합물로는 인산1수소칼륨, 인산2수소칼륨, 황산마그네슘, 염화나트륨, 황산철, 황산망간, 탄산칼슘 등이 사용될 수 있으며, 이외에 필요에 따라 비타민, 아미노산 및 영양요구성 염기 등이 첨가될 수 있다. 배양은 호기적 조건하에, 예를 들면, 진탕배양 또는 통기교반 배양에 의해, 바람직하게는 20∼40℃의 온도에서 수행된다. 배지의 pH는 배양동안 중성 근처에서 유지하는 것이 바람직하며 10-50시간 배양시킨 배양액 또는 원심분리하여 얻어진 균체를 전환반응의 효소원으로 사용한다. XMP의 GMP로의 전환방법은 효소 함유액에 XMP용액 또는 XMP 발효액을 첨가하고 30∼50℃에서 암모니아수나 암모니아 가스로 pH를 7∼8로 조절하면서 24시간 내지 48시간 반응하면 XMP가 GMP로 전환된다. 생성된 GMP는 공지의 방법에 따라 이온교환수지 방법(예 : Dowex 등)에 의해 회수하였다. 그러므로 글루타메이트 생산 코리네형 박테리아인 브레비박테리움 암모니아게네스로부터 유도된 5'-크산틸산 아미나제의 효소합성에 관한 유전정보를 갖는 유전자를 함유하는 재조합 플라스미드에 의해 형질전환된 미생물들을 사용함으로써 기존의 방법들에 비해 효율적으로 GMP를 생산할 수 있다. 본 발명을 상술하면 다음과 같고, 본원에서 사용한 유전자 조작방법을 주로 분자 클로닝 실험 조작법(Molecular Cloning; A laboratory manual, 2nd ed., J. Sambrook, E.F., Fritch, T., Maniatis) 및 분자 클로닝 기술의 지표(Guide to Molecular Cloning Techniques, Methods in Enzymology, vol. 152, S.I., Berger, A.R., Kimme) 등의 방법에 준하여 실시하였으나, 본 발명에 사용된 브레비박테리움 암모니아게네스 ATCC 6872/pGH 16 균주는 1991년 7월 10일자로 한국미생물 보존센터에 기탁하였다.(기탁번호 KCCM 10008)Cultivation of enzyme bacteria giving 5'-xanthyl acid aminase for conversion from XMP to GMP by a transformant carrying a recombinant plasmid can be carried out by a known method. That is, the transformants are cultured in a conventional culture medium containing a carbon source, a nitrogen source, an inorganic compound, amino acids, vitamins and other nutritionally demanding substances under aerobic conditions while controlling the temperature, pH, etc., and the enzyme source for the conversion reaction. Used as As the carbon source, various carbohydrates such as glucose, fructose, storose, maltose, mannose and molasses, various organic acids such as pyruvic acid, fumaric acid, lactic acid and acetic acid can be used, and nitrogen sources include ammonia, ammonium chloride, Various inorganic and organic ammonium salts such as ammonium sulfate, ammonium carbonate and ammonium acetate, urea and other nitrogen-containing substances and peptones, NZ-amines, meat extracts, yeast extracts, corn steep liquors, casein hydrolysates, fish or degradation products thereof, Degreased soy cakes, or degradation products thereof may be used. As the inorganic compound, potassium monohydrogen phosphate, potassium dihydrogen phosphate, magnesium sulfate, sodium chloride, iron sulfate, manganese sulfate, calcium carbonate and the like may be used, and vitamins, amino acids and nutrient-forming bases may be added as necessary. have. The culturing is carried out under aerobic conditions, for example, by shaking culture or aeration stirring, preferably at a temperature of 20 to 40 ° C. The pH of the medium is preferably maintained near neutral during incubation, and the cells obtained by incubation for 10-50 hours or centrifuged are used as the enzyme source for the conversion reaction. XMP is converted to GMP when XMP solution or XMP fermentation broth is added to enzyme-containing solution and reacted for 24 hours to 48 hours while adjusting pH to 7-8 with ammonia water or ammonia gas at 30-50 ℃. . The generated GMP was recovered by an ion exchange resin method (eg Dowex, etc.) according to a known method. Therefore, by using microorganisms transformed by recombinant plasmids containing genes with genetic information on the enzymatic synthesis of 5'-xanthyl acid aminase derived from Brevibacterium ammonia gene, a glutamate producing coryneform bacterium, GMP can be produced more efficiently than methods. The present invention will be described in detail as follows, and the genetic manipulation methods used herein mainly include molecular cloning (A laboratory manual, 2nd ed., J. Sambrook, EF, Fritch, T., Maniatis) and molecular cloning techniques. Although performed according to the method of (Guide to Molecular Cloning Techniques, Methods in Enzymology, vol. 152, SI, Berger, AR, Kimme), the Brevibacterium ammonia genes ATCC 6872 / pGH 16 used in the present invention The strain was deposited with the Korea Microorganism Conservation Center on July 10, 1991. (Accession No. KCCM 10008)

실시예 1Example 1

5'-크산틸산 아미나제 유전자 클로닝5'-Xanthylate Aminase Gene Cloning

브레비박테리움 암모니아게네스 BA 17-2의 염색체 DNA 및 브레비박테리움 암모니아게네스 ATCC 6872/pECCG 117 로부터 pECCG 117분리 BA 17-2 균주를 하기 조성의 C배지에서 32℃, 18시간 진탕배양하여 원심분리로 균체를 회수하고 10ml의 1mM 트리스 완충액(pH 8.0)으로 세척한 뒤 40ml의 라이소자임 반응 완충액(10mM 트리스(pH 8.0), 5mM 염화나트륨, 1mM 에틸렌디아민-4-아세트산(EDTA), 0.5M 슈크로오즈, 10mg/ml 라이소자임)에 현탁시킨 뒤 37℃에서 90분간 처리하였다. 이 세포를 원심분리로 회수하고, 10ml의 슈크로오즈와 라이소자임이 배제된 라이소자임 반응액에 현탁시키고 0.5M EDTA를 0.6ml, 4% SDS를 4.4ml넣어 세포를 분해시켰다. 여기에 염화세슘을 ml당 1g씩 첨가하고 2ml의 에티디움 브로마이드 농축액(10mg/ml)을 섞어주고, 이 혼합액을 초고속 원심분리기(ultracentrifuge)를 사용하여 16℃, 50,000rpm으로 48시간 원심분리시킨 뒤 주사기를 사용하여 염색체 DNA를 취하였다. 이소프로필 알코올로 3∼4회 처리하여 에티디움 브로마이드를 제거한 후 TE 완충액(10mM 트리스(pH 8.0), 1mM EDTA)에서 24시간 투석하여 염색체 DNA를 분리 정제하였다. 셔틀벡터 pECCG 117은 형질전환주 ATCC 6872/pECCG 117로부터 분자클로닝 조작법에 준하여 분리정제하였으며, 이때 배양배지에 가나마이신을 50μg/ml되도록 첨가하였다.Chromosome DNA of Brevibacterium ammonia genes BA 17-2 and pECCG 117 isolated from Brevibacterium ammonia genes ATCC 6872 / pECCG 117 BA 17-2 strains were cultured at 32 ° C. for 18 hours in C medium having the following composition The cells were collected by centrifugation, washed with 10 ml of 1 mM Tris buffer (pH 8.0), and then 40 ml of lysozyme reaction buffer (10 mM Tris (pH 8.0), 5 mM sodium chloride, 1 mM ethylenediamine-4-acetic acid (EDTA), 0.5 M Sucrose, 10 mg / ml lysozyme) and then treated at 37 ° C. for 90 minutes. The cells were recovered by centrifugation, suspended in 10 ml of sucrose and lysozyme excluding lysozyme, and 0.6 ml of 0.5 M EDTA and 4.4 ml of 4% SDS were added to digest the cells. Add 1 g of cesium chloride per ml, mix 2 ml of ethidium bromide concentrate (10 mg / ml), and centrifuge the mixture at 48 ° C and 50,000 rpm for 48 hours using an ultra-centrifuge. The chromosomal DNA was taken using a syringe. Treatment with isopropyl alcohol 3-4 times to remove ethidium bromide, followed by dialysis in TE buffer (10 mM Tris (pH 8.0), 1 mM EDTA) for 24 hours to separate and purify the chromosomal DNA. Shuttle vector pECCG 117 was isolated and purified from the transformant ATCC 6872 / pECCG 117 according to the molecular cloning procedure, at which time kanamycin was added to the culture medium to 50μg / ml.

* C배지 : 효모 추출물 10g/I, 펩톤 10g/I, 염화나트륨 2.5g/I, 우레아 3g/I; pH 7.2C medium: yeast extract 10g / I, peptone 10g / I, sodium chloride 2.5g / I, urea 3g / I; pH 7.2

유전자 라이브러리(genomic library)의 제조Preparation of Genomic Library

BA 17-2 균주로부터 분리 정제된 염색체 DNA를 제한효소 Mbo 1으로 미디움염 제한효소 완충액(50mM 염화나트륨, 10mM 트리스(pH 7.5), 10mM 염화마그네슘, 1mM 디티오쓰레이톨)에서 37℃, 15∼30분간 부분절단(partial digestion)하고, 이 제한효소를 열처리로 불활성화 시킨 뒤 0.7% 저융점 아가로오즈겔(low-melting point agarose gel)에서 전기영동한 뒤 3∼8kb 크기의 DNA절편을 취하였다. 이를 68℃에서 10분간 물로 중탕 가열하여 겔을 녹인 뒤 동일 부피의 트리스 완충액(pH 8.0)으로 포화된 페놀을 섞어준 뒤 원심분리하여 상등액을 취하고 다시 크로로포름 처리 및 에탄올로 침전시켜 목적 유전자원으로 사용하였다. 목적 유전자인 5'-크산틸산 아미나제 유전자의 분리를 위하여 플라스미드 pECCG 117을 제한효소 BamHI으로 고농도염 제한효소 완충액(100mM 염화나트륨, 50mM 트리스(pH 7.5), 10mM 염화마그네슘, 1mM 디티오쓰레이톨)에서 37℃에서 2시간 처리하여 완전 절단하고, 카프 인테스틴 포스파타제(calf intestine phosphatase)를 처리한 뒤 3∼8kb의 BA 17-2 균주의 염색체 DNA절편과 혼합하여 리가제 완충액(0.5M 트리스(pH 7.4), 0.1M 염화마그네슘, 0.1M 디티오쓰레이톨, 10mM 스퍼미딘, 10mM ATP, 1mg/ml 소혈청 알부민)에서 T4 DNA 리가제로 14℃에서 16시간 반응시킴으로써 유전자 라이브러리를 제작하였다.Purified chromosomal DNA from BA 17-2 strain was purified by restriction enzyme Mbo 1 at 37 ° C., 15-30 in medium salt restriction enzyme buffer (50 mM sodium chloride, 10 mM Tris (pH 7.5), 10 mM magnesium chloride, 1 mM dithiothitol). After partial digestion, the restriction enzyme was inactivated by heat treatment, followed by electrophoresis on a 0.7% low-melting point agarose gel, and DNA fragments of 3 to 8 kb were obtained. . This was heated for 10 minutes at 68 ° C with water to dissolve the gel, mixed with phenol saturated with the same volume of Tris buffer (pH 8.0), centrifuged to obtain a supernatant, and then precipitated with chloroform and precipitated with ethanol. Used as. Plasmid pECCG 117 was used as a restriction enzyme BamHI for high concentration salt restriction enzyme buffer (100 mM sodium chloride, 50 mM Tris (pH 7.5), 10 mM magnesium chloride, 1 mM dithiothitol) for isolation of the target gene, 5'-xanthyl acid aminase gene. Complete cleavage by treatment at 37 ° C. for 2 hours, treatment with calf intestine phosphatase, and mixing with chromosomal DNA fragments of 3 to 8 kb BA 17-2 strain followed by ligase buffer solution (0.5 M Tris, pH 7.4). ), 0.1 M magnesium chloride, 0.1 M dithiothreitol, 10 mM spermidine, 10 mM ATP, 1 mg / ml bovine serum albumin) was used to prepare a gene library by reacting with T4 DNA ligase at 14 ° C. for 16 hours.

5'-크산틸산 아미나제의 유전자 클로닝Gene Cloning of 5'-Xanthyl Acid Aminase

아데닌과 구아닌이 첨가된 C배지에서 14∼15시간 배양한 브레비박테리움 암모니아게네스 D 1550∼40 균주를 1ℓ의 동일 배지에 흡광도(600nm)가 0.1 이하가 되도록 접종하고 32℃에서 진탕 배양한 뒤 흡광도가 0.3에 도달했을 때 페니실린 G를 0.3U/ml 되도록 첨가하고 흡광도가 0.6에 도달할 때까지 배양한 뒤 형질전환에 사용하였다. 이 균체를 원심분리하여 회수한 뒤 1ℓ의 1mM N-(2-히드록시에틸)피페라진-N'-(2-에탄설폰산) 완충액으로 1회, 500ml의 냉각된 멸균 탈이온 증류수로 1회, 20ml의 10% 글리세롤 용액으로 2회 세척한 뒤 2∼3ml의 10% 글리세롤 용액에 현탁시켜 사용하였다. 이 현탁액을 적당량으로 나누어 드라이아이스로 급속냉동시킨 뒤 -70℃에 보관하면 형질전환 빈도의 감소없이 약 1개월 동안 사용가능하다. 냉동된 균체의 현탁액을 얼음 속에서 서서히 녹인 뒤 여기에 적당량의 유전자 라이브러리 DNA를 첨가하여 잘 섞어주고 전기장 충격장치(Bio-Rad, Gene Pulser)로 1회 전기장 충격을 가한 뒤 1ml C배지에 현탁하여 32℃에서 1시간 배양한 뒤 멸균된 생리 식염수로 세척한 뒤 100mg/ℓ의 아데닌과 50μg/ml의 가나마이신이 포함된 하기 조성의 최소 한천 평판 배지에 도말하여 1∼5일 배양하여 형질전환체를 얻을 수 있었다.Brevibacterium ammonia genes D 1550-40 strain incubated for 14 to 15 hours in C medium containing adenine and guanine was inoculated in 1 L of the same medium so that absorbance (600 nm) was 0.1 or less, followed by shaking culture at 32 ° C. Then, when the absorbance reached 0.3, penicillin G was added to 0.3 U / ml, and cultured until the absorbance reached 0.6, and then used for transformation. The cells were recovered by centrifugation and then once with 1 L of 1 mM N- (2-hydroxyethyl) piperazine-N '-(2-ethanesulfonic acid) buffer and once with 500 ml of cooled sterile deionized distilled water. After washing twice with 20 ml of 10% glycerol solution, it was suspended and used in 2-3 ml of 10% glycerol solution. This suspension can be divided into suitable portions and rapidly frozen in dry ice and stored at -70 ° C for use for about one month without decreasing the frequency of transformation. After slowly dissolving the frozen cell suspension in ice, add an appropriate amount of gene library DNA to it, mix it well, apply the electric field shock with a field shock device (Bio-Rad, Gene Pulser), and then suspend it in 1 ml C medium. After 1 hour incubation at 32 ℃ washed with sterile physiological saline and then plated on at least agar plate medium of the following composition containing 100mg / L adenine and 50μg / ml kanamycin and cultured for 1 to 5 days transformants Could get

* 최소 한천 평판 배지 : 글루코오즈 10g/ℓ, 황산암모늄2g/ℓ, 요소 2g/ℓ, 인산1수소칼륨 0.2g/ℓ, 인산2수소칼륨 0.2g/ℓ, 황산마그네슘 0.1g/ℓ, 염화칼슘 0.1g/ℓ, d-비오틴 100μg/ℓ, 염산티아민 100μg/ℓ, 보락스 88mg/ℓ, 몰리브덴산암모늄 36mg/ℓ, 황산아연 8.8mg/ℓ, 황산구리270mg/ℓ, 염화망간 7.7mg/ℓ, 염화제1철 970mg/ℓ, 한천 20g/ℓ; pH 7.2* Minimum agar plate medium: Glucose 10g / ℓ, Ammonium sulfate 2g / ℓ, Urea 2g / ℓ, Potassium dihydrogen phosphate 0.2g / ℓ, Potassium dihydrogen phosphate 0.2g / ℓ, Magnesium sulfate 0.1g / ℓ, Calcium chloride 0.1 g / l, d-biotin 100μg / l, thiamine hydrochloride 100μg / l, borax 88mg / l, ammonium molybdate 36mg / l, zinc sulfate 8.8mg / l, copper sulfate 270mg / l, manganese chloride 7.7mg / l, chloride Ferrous 970 mg / l, agar 20 g / l; pH 7.2

실시예 2Example 2

브레비박테리움 형질전환주에서의 5'-크산틸산 아미나제의 발현Expression of 5'-Xanthyl Acid Aminase in Brevibacterium Transformants

실시예 1에서 얻어진 형질전환체들로부터 통상의 방법에 의해 플라스미드 DNA를 분리하여 6.5kb의 염색체 DNA를 포함하는 플라스미드 pGH 16을 얻을 수 있었으며, 이 재조합 플라스미드를 브레비박테리움 암모니아게네스 ATCC 6872 와 BA 17-2 및 D 1550-40 균주들에 형질전환시켜 형질전환체들의 5'-크산틸산 아미나제의 효소 활성을 측정하였다. 효소액을 얻기 위하여 형질전환체들을 C배지(필요한 경우 가나마이신을 50μg/ml되게 첨가하고 아데닌, 구아닌을 소량첨가)에서 대수증식기까지 키운 후 원심분리하여 균체를 회수하고 적당량의 0.1M 트리스 완충액(pH7.3)에 현탁하여 초음파 균체분쇄기(ultrasonicator)로 균체를 분쇄한 뒤 원심분리하여 얻어진 상등액을 효소액으로 사용하였다. 이렇게 하여 얻어진 효소액의 적당량을 2.4ml의 5'-크산틸산 아미나제 반응액(0.16M 트리스(ph 7.6), 4mM ATP, 16mM 염화마그네슘, 25mM XMP, 0.33m 황산암모늄)에 첨가하여 35∼50℃에서 30분∼1시간 반응시킨 뒤, 30ml의 3.5% 트리클로로아세트산을 첨가하고 원심분리하여 상등액의 흡광도를 290nm에서 측정하였다. 그 결과 D 1550-40 균주에서는 5'-크산틸산 아미나제의 역가가 나타나지 않는데 반해 형질전환주 D 1550-40/pGH 16에서 5'-크산틸산 아미나제의 역가가 발현됨을 볼 수 있었으며, 형질전환주 ATCC 6872/pGH 16와 BA 17-2/pGH 16의 경우에는 모 균주에서 비해 각각 약 14배, 10배정도의 5'-크산틸산 아미나제의 비효소 활성(specific enzyme activity)의 증가를 볼수 있었고, 자세한 결과는 표 2에 기재하였다.Plasmid DNA was isolated from the transformants obtained in Example 1 by a conventional method to obtain plasmid pGH 16 containing 6.5 kb of chromosomal DNA. The recombinant plasmid was converted into Brevibacterium ammonia genes ATCC 6872 and BA 17-2 and D 1550-40 strains were transformed to determine the enzymatic activity of 5′-xanthyl acid aminase of the transformants. To obtain the enzyme solution, the transformants were grown from C medium (if necessary, 50 μg / ml of kanamycin and small amounts of adenine and guanine) were grown to logarithmic growth, followed by centrifugation to recover the cells and an appropriate amount of 0.1M Tris buffer (pH7). The supernatant obtained by suspending in .3) and pulverizing the cells with an ultrasonic cell grinding machine (ultrasonicator) and centrifuging was used as the enzyme solution. An appropriate amount of the enzyme solution thus obtained was added to 2.4 ml of 5'-xanthyl acid aminase reaction solution (0.16 M Tris (ph 7.6), 4 mM ATP, 16 mM magnesium chloride, 25 mM XMP, 0.33 m ammonium sulfate) After reacting for 30 minutes to 1 hour, 30 ml of 3.5% trichloroacetic acid was added and centrifuged to measure the absorbance of the supernatant at 290 nm. As a result, the titer of 5'-xanthyl acid aminase was not expressed in D 1550-40 strain, whereas the titer of 5'-xanthyl acid aminase was expressed in transformant D 1550-40 / pGH 16. In the case of ATCC 6872 / pGH 16 and BA 17-2 / pGH 16, the specific enzyme activity of 5'-xanthyl acid aminase was increased by 14 and 10 times, respectively. , Detailed results are listed in Table 2.

* 효소활성의 단위(U)는 반응 후 단위시간당 290nm에서의 흡광도의 증가로써 표시하였다.* The unit (U) of enzyme activity was expressed as an increase in absorbance at 290 nm per unit time after the reaction.

실시예 3Example 3

코리네박테리움 및 에쉐리시아 속의 형질전환주에서의 5'-크산틸산 아미나제의 발현Expression of 5'-xanthyl acid aminase in transformants of the genus Corynebacterium and Escherichia

재조합 플라스미드 pGH 16을 형질전환하여 얻어진 형질전환주 코리네박테리움 글루타미쿰 ATCC 13032/pGH 16과 에쉐리시아 콜리 W 3110/pGH 16을 실시예 1과 동일한 방법으로 5'-크산틸산 아미나제의 효소 역가 분석을 수행하였다. 그 결과 표1에서 보는 바와 같이 코리네박테리움과 에쉐리시아 속의 균주에서도 발현이 되었으며 비 효소 역가가 각각 약 5배 및 2배 증가됨을 확인할 수 있었다.The transformants Corynebacterium glutamicum ATCC 13032 / pGH 16 and Escherichia coli W 3110 / pGH 16 obtained by transforming the recombinant plasmid pGH 16 were prepared in the same manner as in Example 1 to obtain 5'-xanthyl acid aminase. Enzyme titer analysis was performed. As a result, as shown in Table 1, it was expressed in strains of Corynebacterium and E. coli, and the non-enzyme titers were confirmed to be increased by about 5 and 2 times, respectively.

실시예 4Example 4

형질전환주에 의한 XMP의 GMP로의 전환반응Conversion of XMP to GMP by Transformants

C배지를 종 배양배지로 하여 500ml의 진탕용 삼각 플라스크에 30ml씩 분주하고 120℃에서 15분간 가압 살균하여 형질전환주 BA 17-2/pGH 16균을 1백금이 식균한 후 30℃에서 24시간 배양하여 종배양액으로 사용하였다. 또한 하기의 발효배지 1.5ℓ를 5ℓ 발효조에 넣고 120℃에서 30분간 가압 살균한 후 종배양액을 2% 용량으로 식균하여 30℃, pH 7.0으로 3일간 배양하였다. 이때 회전속도는 750rpm, 공기첨가속도는 1vvm으로 하였다. 배양이 완료된 효소균체 함유액에 XMP를 최종 농도 20mg/ml되게 첨가하고 35∼50℃에서 pH를 7.0∼8.0으로 유지시키면서 24시간 반응시켰으며 이때 대조군으로 모균주 BA 17-2를 병행하여 실시하였다. 전환 반응의 시작은 적당량의 계면활성제(SDS, Hyamine 등)를 첨가함으로써 시작하였다. 반응 중 경시적인 GMP의 전환율은 표 3에 게재하였으며, 표 4에서 볼 수 있듯이 전환반응의 속도는 약 3배 증가하였고 전환율도 67%에서 약 50% 향상되었다.C medium was used as a seed culture medium, and 30 ml each of 500 ml shaking Erlenmeyer flasks was autoclaved at 120 ° C. for 15 minutes, and 16 cells of transformed BA 17-2 / pGH were inoculated with platinum for 24 hours at 30 ° C. The culture was used as the seed culture solution. In addition, 1.5 liter of the fermentation broth was added to a 5 L fermenter, followed by autoclaving at 120 ° C. for 30 minutes, and the seed culture solution was inoculated at a 2% capacity and incubated at 30 ° C. and pH 7.0 for 3 days. At this time, the rotation speed was 750rpm, the air addition speed was 1vvm. XMP was added at a final concentration of 20 mg / ml to the enzyme-containing culture medium, and the reaction was carried out for 24 hours while maintaining the pH at 7.0 to 8.0 at 35 to 50 ° C. At this time, the parent strain BA 17-2 was performed as a control. . The start of the conversion reaction was started by adding an appropriate amount of surfactant (SDS, Hyamine, etc.). The conversion rate of GMP over time during the reaction is shown in Table 3. As shown in Table 4, the rate of the conversion reaction increased about three times and the conversion rate also improved from 67% to 50%.

* 발효배지 : 글루코오즈 100g/ℓ, 인산제1,2수소칼륨 각 10g/ℓ, 황산마그네슘 10g/ℓ, 염화칼슘 0.1g/ℓ, 황산철 10mg/ℓ, 황산망간 2mg/ℓ, 효모추출물 10g/ℓ, 카세인 가수분해물 10g/ℓ, d-비오틴 30μg/ℓ, 아데닌 10mg/ℓ, pH 8.5* Fermentation medium: 100g / l glucose, 10g / l potassium phosphate 1,2g, 10g / l magnesium sulfate, 0.1g / l calcium chloride, 10mg / l iron sulfate, 2mg / l manganese sulfate, 10g / yeast extract l, casein hydrolyzate 10 g / l, d-biotin 30 μg / l, adenine 10 mg / l, pH 8.5

Claims (1)

브레비박테리움 암모니아게네스로부터 클로닝된 5'-크산틸산 아미나제 유전자를 함유하고 있고 코리네형 글루타메이트 생산 박테리아 및 대장균에서 복제 및 발현이 가능한 발현 비히클 pGH 16으로 형질전환된 코리네형 글루타메이트 생산 미생물-브레비박테리움 암모니아게네스 ATCC 6872/pGH 16-인 KCCM-10008.Coryneform glutamate producing microorganisms containing the 5'-xanthylate aminase gene cloned from Brevibacterium ammonia genes and transformed with the expression vehicle pGH 16 that are cloned and expressed in coryneform glutamate producing bacteria and E. coli Non-bacterium ammonia genes ATCC 6872 / pGH 16- phosphorus KCCM-10008. 2. 브레비박테리움 암모니아게네스로부터 클로닝된 5'-크산틸산 아미나제 유전자를 함유하고 있고 코리네형 글루타메이트 생산 박테리아 및 대장균에서 복제 및 발현이 가능한 발현 비히클 pGH 16으로 형질전환된 코리네형 글루타메이트 생산 미생물-브레비박테리움 암모니아게네스 ATCC 6872/pGH 16-인 KCCM-10008을 배양배지에 배양하여, XMP를 GMP로 전환시키고, 그로부터 GMP를 회수함을 특징으로 하는 GMP의 제조방법.2. Coryneform glutamate producing microorganisms containing the 5'-xanthyl acid aminase gene cloned from Brevibacterium ammonia genes and transformed with the expression vehicle pGH 16 which can be cloned and expressed in coryneform glutamate producing bacteria and E. coli. -Brevibacterium ammonia gene ATCC 6872 / pGH 16- KCCM-10008 incubated in a culture medium, converting XMP to GMP, and the method of producing GMP, characterized in that to recover GMP therefrom.
KR1019910013227A 1991-07-31 1991-07-31 Process for gmp by recombinant microorganism Expired - Fee Related KR970005914B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019910013227A KR970005914B1 (en) 1991-07-31 1991-07-31 Process for gmp by recombinant microorganism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019910013227A KR970005914B1 (en) 1991-07-31 1991-07-31 Process for gmp by recombinant microorganism

Publications (2)

Publication Number Publication Date
KR930002508A KR930002508A (en) 1993-02-23
KR970005914B1 true KR970005914B1 (en) 1997-04-22

Family

ID=19318082

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910013227A Expired - Fee Related KR970005914B1 (en) 1991-07-31 1991-07-31 Process for gmp by recombinant microorganism

Country Status (1)

Country Link
KR (1) KR970005914B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101960005B (en) 2008-02-25 2016-02-24 味之素株式会社 Production method of 5'-guanylic acid

Also Published As

Publication number Publication date
KR930002508A (en) 1993-02-23

Similar Documents

Publication Publication Date Title
KR100575403B1 (en) Increasing cellular NADPH to produce L-amino acids
KR20000076602A (en) Process for producing purine nucleotides
JPH0716431B2 (en) Process for producing 5'-guanylic acid
JP2886547B2 (en) Method for producing neuraminidase
HU216653B (en) Process for recombinant preparation of polipeptides involved in the biosynthesis of cobalamines and/or cobamides
KR970005914B1 (en) Process for gmp by recombinant microorganism
JP3369236B2 (en) Method for producing choline cytidine diphosphate
US4670389A (en) Process for producing N-acetylneuraminate lyase
US4598046A (en) Mutant strain of Escherichia coli and its use for the preparation of glutathione
JP3117707B2 (en) Method for producing 5'-inosinic acid
KR970005915B1 (en) Process for gmp by recombinant microorganism
KR970005916B1 (en) Process for gmp by recombinant microorganism
KR970005917B1 (en) Process for gmp by recombinant microorganism
JPS62186795A (en) Production of amino acid
US5250425A (en) Process for producing ascorbic acid-2-phosphate
KR960007743B1 (en) Method for preparing 5'-guanylic acid by recombinant microorganism
KR970001562B1 (en) New plasmid and transformed microorganism and process for nucleic acid
KR100434108B1 (en) Genetic engineering of L-tryptophan
KR100498897B1 (en) Mutant strain of E. coli having decreased nucleic acid-decomposing capability and increased protein-producing capability
JP3489604B2 (en) 5-aminolevulinic acid synthase gene
JPS63157986A (en) Production of l-phenylalanine by gene recombination
WO1985004187A1 (en) Process for preparing 5'-guanylic acid
JP3508871B2 (en) DNA having genetic information of protein having creatinine deiminase activity and method for producing creatinine deiminase
KR0185577B1 (en) Gene amplification vector and preparation method of 5'-guanisyl acid
US5514574A (en) Method of producing flavine nucleotides

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

FPAY Annual fee payment

Payment date: 20070628

Year of fee payment: 11

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 11

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R14-asn-PN2301

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20080815

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20080815

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000